AI Test Detects Pancreatic Cancer Up to Three Years Early

Dr. Rachel Mendez MD, Medical Science Writer

✨ Why this is good news

Pancreatic cancer is a deadly disease often found too late, but a new AI test may catch it early.

Up to three years earlier.The AI tool can detect pancreatic cancer up to three years before a standard diagnosis. Before this, the disease was usually caught too late for curative surgery, drastically lowering survival chances.
Reads “normal” scans differently.The AI analyzes CT scans that look normal to the human eye, finding subtle cancer signatures before tumors form. This means patients can be treated much earlier, when the cancer is still curable.
Tested on nearly 2,000 scans.The tool was validated using about 2,000 CT scans in a study published in the journal Gut. This large dataset gives doctors confidence the AI works reliably in real world settings.
Mayo Clinic breakthrough.Mayo Clinic researchers developed this AI, marking a major step forward in oncology. Previously, no reliable screening existed for pancreatic cancer, leaving most patients diagnosed too late for effective intervention.

Mayo Clinic researchers have developed an artificial intelligence tool that can spot pancreatic cancer up to three years before patients receive a diagnosis, offering a critical window for curative treatment. The breakthrough addresses one of the deadliest challenges in oncology: catching the disease before it spreads.

The AI assisted test model analyzes CT scans that appear normal to the human eye, identifying subtle signatures of cancer before tumors visibly form. In a study published in the journal Gut, the tool reviewed approximately 2,000 CT scans, including those from patients later diagnosed with pancreatic cancer. While the scans were initially interpreted as normal, the AI helped doctors detect prediagnostic cancers at nearly double the rate of specialists examining the scans without AI assistance. Scans reviewed more than two years before an official diagnosis were three times more effective at catching early cancers.

“The greatest barrier to saving lives from pancreatic cancer has been our inability to see the disease when it is still curable,” said Dr. Ajit Goenka, the study’s senior author and a Mayo Clinic radiologist and nuclear medicine specialist. “This AI can now identify the signature of cancer from a normal appearing pancreas, and it can do so reliably over time and across diverse clinical settings.” The research was conducted as part of Mayo Clinic’s Precure initiative, a program focused on predicting and preventing diseases by detecting early biological changes in the body before symptoms begin.

What This Means for Patients

Pancreatic cancer is notoriously difficult to detect early, often diagnosed at advanced stages when treatment options are limited. By identifying the disease up to three years earlier, this AI tool could dramatically improve survival rates. Patients would have more time to seek surgery, chemotherapy, or other interventions while the cancer remains localized and potentially curable.

The next steps involve broader clinical validation and integration into routine screening, particularly for high risk populations such as those with a family history of pancreatic cancer or genetic predispositions. Researchers are optimistic that this approach could eventually be adapted for other hard to detect cancers, expanding the reach of AI driven early detection. For now, the tool represents a hopeful leap forward in turning one of the most lethal cancers into a more manageable and survivable disease.

This article is for informational purposes only and does not constitute medical advice. The information presented is based on published research and official announcements. Always consult a qualified healthcare professional before making any medical decisions.